Skip to content

The psychological and economic impact of endometriosis

The psychological and economic impact of endometriosis

The psychological and economic impact of endometriosis

The psychological and economic impact of endometriosis

We’re thrilled to present the third episode of Scailyte’s Endometriosis Awareness Series, where Cinzia Donato interviews Dr. Alina Staikov on “The psychological and economic impact of endometriosis”.

Dr. Staikov is a specialized gynecologist with a wealth of experience in the field. She completed her medical studies at the University of Sofia and specialized in gynecology and obstetrics at the Ruppiner Kliniken, an educational hospital of Charité in Berlin. Her passion for women’s health led her to establish gynecological and obstetrical consulting at the Center for Integrative Medicine in Zurich and work as a senior specialist at Seespital Horgen. Dr. Staikov is also certified in educational programs in gynecology and obstetrics.

In 2019, Dr. Staikov founded Gynpoint, a gynecology and obstetrics practice with locations in Zurich and Horgen, where she offers the whole spectrum of modern diagnostics and therapeutics. With over 7000 patients consulted each year, she has gained invaluable insights into the challenges faced by women with endometriosis.

Dr. Staikov plays an essential role in raising awareness of endometriosis as a collaborator with the Endometriosevereinigung-Schweiz. Her dedication to educating and supporting patients is commendable, and we’re honored to have her share her expertise in our interview.

Join us as we delve into endometriosis awareness among different age groups, the benefits of early diagnosis and the psychological and economic impact of endometriosis with Dr. Alina Staikov. Gain valuable insights into this complex condition and its far-reaching effects on women’s lives.

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Scailyte Extends Series A to USD 8 Million

We are thrilled to announce the extension of our Series A funding, bringing the total raised amount ...

Read more

Recent News

ScaiDigest Volume 6: Variational autoencoders (VAEs) in biology

Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell anal...

Read more

Recent News

Pitch-nic Expo

We're excited to share that our Senior Vice President of Corporate & Technology Development, Corinne...

Read more

Recent News

Targets & Cell Types in Immuno-Oncology Europe 2023

Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in B...

Read more

Recent News

Unravelling the AI Executive Order: A Discussion with Our CEO and Head of Regulatory Affairs

We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI l...

Read more

Recent News

NextGen Omics 2023

Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in Lon...

Read more

Recent News

SITC 2023

Diana Stoycheva and Julian Spagnuolo will be sharing Scailyte’s science at a poster #201, and will...

Read more

Recent News

ScaiDigest Volume 5: Unlocking the Secrets of AML

Read Diana's insightful post and stay at the forefront of scientific advancements in the field!

Read more

Recent News

01 /04

Scailyte Extends Series A to USD 8 Million

We are thrilled to announce the extension of our Series A funding, bringing the total raised amount ...

Read more

ScaiDigest Volume 6: Variational autoencoders (VAEs) in biology

Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell anal...

Read more

Recent News

02 /04

Pitch-nic Expo

We're excited to share that our Senior Vice President of Corporate & Technology Development, Corinne...

Read more

Targets & Cell Types in Immuno-Oncology Europe 2023

Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in B...

Read more

Recent News

03 /04

Unravelling the AI Executive Order: A Discussion with Our CEO and Head of Regulatory Affairs

We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI l...

Read more

NextGen Omics 2023

Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in Lon...

Read more

Recent News

04 /04

SITC 2023

Diana Stoycheva and Julian Spagnuolo will be sharing Scailyte’s science at a poster #201, and will...

Read more

ScaiDigest Volume 5: Unlocking the Secrets of AML

Read Diana's insightful post and stay at the forefront of scientific advancements in the field!

Read more

Recent News